Search results for

Almost everyone agrees that the much-hyped boxing match between Floyd Mayweather and MMA champ Conor McGregor will not be much of a fight. But fans will shell out an estimated half a billion dollars to watch. NPR's Robert Siegel talks with sports columnist Adam Kilgore of The Washington Post about the fight.

What options do Senate Republicans have left in their effort to undo the Affordable Care Act, which is also known as Obamacare? The stakes seem much bigger than just health care.

The man who caused a firestorm of criticism after he bought a small pharmaceutical company and jacked up the price of a life-saving drug was found guilty Friday of securities fraud. Martin Shkreli was convicted on three of the eight fraud charges he faced and could be sentenced to a prison term of as much as 20 years.

President Trump arrives in Paris on Thursday and will be a guest of honor at France's Bastille Day celebrations and hold talks with France's president, Emmanuel Macron.

The Northeast Canyons and Seamounts Marine National Monument off the coast of New England is the size of Connecticut and has been called an "underwater Yellowstone" and "a deep sea Serengeti."

Climbing drug prices are taking a toll on West Virginia's budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.

We pitted two political pundits against an algorithm to compete at predicting the biggest issues to arise over a month in the presidential election. Now we find out who won.

Haley has accepted an offer from President-elect Donald Trump to lead the U.S. delegation to the United Nations. During the presidential campaign, she had been very critical of Trump.

Since the unrest in Baltimore a year ago, new police chief Kevin Davis openly criticizes the Baltimore police department's old strategies — and says he wants to police "smarter."

New Hampshire's attorney general claims five drug companies are stifling an investigation into how they market opioids. The allegations are the latest in a string of legal actions that aim to hold drug companies accountable for a spike in opioid abuse.